Patient info Open main menu

Syntocinon® 5 IU/ml and 10 IU/ml – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
10 IU/ml
Contains active substance:
ATC code:
Similar medicines:

Patient leaflet - Syntocinon 10 IU/ml concentrate for solution for infusion

1. What Syntocinon is and what it is used for

Syntocinon contains a manufactured form of oxytocin (a natural hormone). It belongs to a group of medicines called oxytocics that make the muscles of the womb contract.

Syntocinon is used:

  • to start or help contractions during childbirth (labour)
  • to help in the management of a miscarriage
  • to prevent and control bleeding after delivery of your baby
  • during a caesarean section.

2. What you need to know before you receive Syntocinon

You must not receive Syntocinon:

  • if you are allergic to oxytocin or any of the ingredients of this medicine (listed in section 6)
  • if your doctor thinks that to start or increase contractions of the womb would be unsuitable for you, for example:

    • where contractions of the womb are unusually strong
    • where there are obstructions that may prevent delivery
    • where your baby may be short of oxygen
  • where labour or vaginal delivery is not advisable, for example:

    • if your baby’s head is too large to fit through your pelvis
  • if your baby is wrongly positioned in the birth canal
  • if the placenta lies near or over the neck of your womb
  • if your baby lacks oxygen due to blood vessels running across the neck of your womb
  • if the placenta separates from the womb before the baby is born
  • if there are one or more loops of umbilical cord between the baby and the neck of the womb, either before or after your waters break
  • if your womb is over-extended and more likely to tear, for example if you are carrying more than one baby or have too much water (amniotic fluid) in your womb
  • if you have had five or more pregnancies in the past or if your womb is scarred by previous caesarean section or other surgery
  • if you have been given medicines called prostaglandins (used to bring on labour or treat stomach ulcers). Syntocinon should not be used for 6 hours after vaginal prostaglandins as the effects of both medicines may be increased Syntocinon should not be used for prolonged periods if:
  • your contractions do not increase with the treatment
  • you have a condition known as severe pre-eclampsia (high blood pressure, protein in the urine and swelling)
  • you have severe problems with your heart or blood circulation.

Warnings and precautions

Syntocinon should only be administered by a healthcare professional in a hospital setting. Syntocinon should not be given as rapid injection into a vein as this may cause low blood pressure, a sudden brief sensation of heat (often over the entire body), and an increased heart rate.

Before you receive Syntocinon tell your doctor or midwife if:

  • you are prone to chest pain due to pre-existing heart and/or circulation problems
  • you have a known irregular heart beat (‘long QT syndrome’) or related symptoms, or are taking medicines known to cause the syndrome (see section ‘Other medicines and Syntocinon’)
  • you have had a previous caesarean section
  • you are more than 35 years old
  • you have raised blood pressure or heart problems
  • your womb was contracting strongly but has now begun to contract less strongly
  • you have been told by a doctor or midwife that normal delivery may be difficult for you due to the small size of your pelvis
  • you have kidney problems, as Syntocinon can cause water retention
  • you have had complications during your pregnancy
  • you are more than 40 weeks pregnant. When Syntocinon is given to induce and enhance labour, the infusion rate should be set to maintain a contraction pattern similar to normal labour and adjusted to individual response. Too high doses may cause very strong continuous contractions and possibly tearing of the womb, with serious complications for you and your baby.

    Syntocinon may rarely cause disseminated intravascular coagulation which causes symptoms including abnormal blood clotting, bleeding and anaemia. High doses of Syntocinon may force amniotic fluid from your womb into your blood. This is known as amniotic fluid embolism.

    Large doses of Syntocinon over a long period of time, whilst drinking or receiving large volumes of fluid may make your stomach feel very full, cause difficulty in breathing and lower salt levels in your blood. If any of the above applies to you, or if you are not sure, speak to your doctor or midwife before you receive Syntocinon.

    Latex allergy

    The active substance in Syntocinon might cause a severe allergic reaction (anaphylaxis) in patients with latex allergy. Please tell your doctor if you know you are allergic to latex.

    Other medicines and Syntocinon

    Tell your doctor or midwife if you are taking or have recently taken any of the following medicines as they may interfere with Syntocinon:

    • prostaglandins (used to start labour or to treat stomach ulcers) and similar drugs as the effects of both drugs may be increased
    • medicines that can cause an irregular heartbeat, as Syntocinon may increase this effect
    • anaesthetics which you breathe in (e.g. to put you to sleep during surgery), such as halothane, cyclopropane, sevoflurane or desflurane) as these may weaken your contractions, or cause problems with your heartbeat
    • anaesthetic medicines for local or regional pain relief, in particular an epidural for pain relief during labour. Syntocinon may increase the blood vessel narrowing effect of these medicines and cause an increase in blood pressure.

Please tell your doctor or midwife if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. Syntocinon with food and drink

You may be told to keep the amount of fluids you drink to a minimum.

Pregnancy and breast-feeding

Based on wide experience of use and the nature of this medicine, it is not expected that Syntocinon would be a risk to your baby when used correctly. Syntocinon may be found in small amounts in breast milk but is not expected to have harmful effects because it is quickly inactivated by your baby’s digestive system. Driving and using machines

Syntocinon can start labour. Women with contractions should not drive or use machines. Information on sodium content

This medicine contains less than 1 mmol sodium

3. How Syntocinon is given to you

Your doctor or midwife will decide when and how to treat you with Syntocinon. If you think that the effect of Syntocinon is too strong or too weak, tell your doctor or midwife. While you are receiving Syntocinon, both you and your baby will be 2 Syntocinon is usually diluted before use and given as an intravenous infusion (drip) into one of your veins. The usual dose is different in the following circumstances:

To start or help contractions during labour

The rate of infusion will start at 2 to 8 drops per minute. This may be gradually increased to a maximum rate of 40 drops per minute. The infusion rate can often be reduced once the contractions reach an adequate level, about 3-4 contractions every 10 minutes.

If your contractions do not reach the adequate level after 5 IU the attempt to start labour should be stopped and then repeated the following day. Miscarriage

The dose is 5 IU by infusion into a vein. In some cases this may be followed by a drip at 40 to

Caesarean section

The dose is 5 IU by infusion into a vein immediately after delivery of your baby.

Prevention of bleeding after delivery

The dose is 5 IU by infusion into a vein after delivery of the placenta.

Treatment of bleeding after delivery

The dose is 5 IU by infusion into a vein. In some cases this may be followed by a drip containing 5 to 20 IU of oxytocin.

Elderly (65 years and over)

There is no information on use in elderly patients. Syntocinon is not intended for use in the elderly. Children and adolescents

There is no information on use in children

is not intended for use in children or adolescents. Patients with kidney disease

There is no information on use in patients with kidney disease.

However, you should tell your doctor if you suffer from kidney problems (see section 2 ‘Warnings and precautions’)

Patients with liver disease

There is no information on use in patients with liver disease.

What to do if you receive more Syntocinon than you should

As this medicine is given to you in hospital, it is very unlikely that you will receive an overdose. If anyone accidentally receives this medicine, tell the hospital accident and emergency department or a doctor immediately. Show any left over medicines or the empty packet to the doctor.

An overdose of Syntocinon could cause:

  • very strong contractions of your womb
  • damage to your womb which could include tearing
  • the placenta to come away from your womb
  • amniotic fluid (the fluid around the baby) to enter your bloodstream
  • harm to your baby.

    What to do if you miss a dose

    As a doctor or midwife is giving you this medicine, you are unlikely to miss a dose.

    If you have any further questions on the use of this medicine, ask your doctor or midwife.

4. Possible side effects

Like all medicines, Syntocinon can cause side effects, although not everyone gets them. Your doctor may consider it necessary to treat the side effects of Syntocinon with other medicines. Some side effects could be serious. If any of the following occur, tell your doctor straight away:

The following side effect may affect between 1 and 10 in every 10,000 patients:

  • a severe allergic (anaphylactic/anaphylactoid) reaction with difficulty in breathing, dizziness and lightheadedness, feeling faint, nausea, cold and clammy skin or a fast or weak pulse
  • Swelling of the face, lips, tongue, throat, and/or extremities (possible signs of angioedema) The following side effects have been reported in Syntocinon

Common side effects (more than 1 in 100 patients) of Syntocinon include:

  • feeling or being sick
  • headache
  • fast or slow heartbeat

Uncommon side effects (more than 1 in

  • an irregular heartbeat.

Rare side effects (more than 1 in 10,000 patients) of Syntocinon include:

  • skin rashes

Other side effects

Effects in the mother:

  • haemorrhage (bleeding)
  • chest pain (angina)
  • irregular heartbeat
  • excessive or continuous contractions
  • tearing of the womb
  • fluid retention (water intoxication). Symptoms may include headache, anorexia (loss of appetite), feeling or being sick, stomach pain, sluggishness, drowsiness, unconsciousness, low levels of certain chemicals in the blood (e.g. sodium or potassium), fits
  • low blood salt levels
  • sudden fluid overload in the lungs
  • sudden brief sensation of heat often over the whole body
  • abnormal clotting, bleeding and anaemia
  • spasm of the muscles of the womb

Effects in the baby:

Excessive contractions may cause low blood salt levels, shortage of oxygen, suffocation and death. Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or midwife. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see below). By reporting side effects you can help provide more information on the safety of this medicine. 3 Method of administration for each indication, continued:

Incomplete, inevitable or missed abortion

5 IU by i.v. infusion (5 IU diluted in physiological electrolyte solution and administered as an i.v. drip infusion or preferably, by means of a variable-speed infusion pump over 5 minutes), if necessary followed by i.v. infusion at a rate of 20 to 40 milliunits/minute.

Caesarean section

5 IU by i.v. infusion (5 IU diluted in physiological electrolyte solution and administered as an i.v. drip infusion or, preferably, by means of a variable-speed infusion pump over 5 minutes) immediately after delivery. Prevention of postpartum uterine haemorrhage

The usual dose is 5 IU by i.v. infusion (5 IU diluted in physiological electrolyte solution and administered as an i.v. drip infusion or, preferably, by means of a variable-speed infusion pump over 5 minutes) after delivery of the placenta. In women given Syntocinon for induction or enhancement of labour, the infusion should be continued at an increased rate during the third stage of labour and for the next few hours thereafter. Treatment of postpartum uterine haemorrhage

5 IU by i.v. infusion (5 IU diluted in physiological electrolyte solution and administered as an i.v. drip infusion or, preferably, by means of a variable-speed infusion pump over 5 minutes), followed in severe cases by i.v. infusion of a solution containing 5 to 20 IU of oxytocin in 500ml of an electrolyte-containing diluent, run at the rate necessary to control uterine atony.

Note - Syntocinon should not be infused via the same apparatus as blood or plasma, because the peptide linkages are rapidly inactivated by oxytocin- inactivating enzymes. Syntocinon is incompatible with solutions containing sodium metabisulphite as a stabiliser.

Storage - Store between 2º and 8ºC.

Syntocinon is a registered trademark.

United Kingdom Yellow Card Scheme

Website: www.mhra.gov.uk/ yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

5. How to store Syntocinon

Keep this medicine out of the sight and reach of

children.

The hospital pharmacy will store this medicine in a

refrigerator between 2º to 8°C and make sure that

it is not used after the expiry date on the pack. The

expiry date refers to the last day of that month.

Chemical and physical in-use stability has been

demonstrated for 24 hours at room temperature

(15 °C to 25 °C).

From a microbiological point of view, unless the

method of opening/ reconstitution/ dilution

precludes the risk of microbial contamination, the

product should be used immediately. If not used

immediately, in-use storage times and conditions are

the responsibility of the user.

If your doctor decides to stop your treatment, return

any unused medicine to the pharmacist. Only keep it

if your doctor tells you to.

Medicines should not be disposed of via wastewater

or household waste. Ask your pharmacist on how

to dispose of medicines no longer required. These

measures will help protect the environment. ART-XXXXX-XX

6. Contents of the pack and other information

What Syntocinon contains

The active substance is oxytocin.

The other ingredients are sodium acetate tri-hydrate, sodium chloride, acetic acid and water for injections. What Syntocinon looks like and contents of the pack

Syntocinon is a clear, colourless, sterile liquid which comes in a 1ml (millilitre) clear glass ampoule. Syntocinon comes in packs of five ampoules. Each Syntocinon ampoule contains either 5 IU (International Units) or 10 IU oxytocin.

Marketing Authorisation Holder

CD Pharmaceuticals AB

Uppsala Sweden

quality-pv@cdpharmagroup.one

Manufacturer

Viatris UK Healthcare Limited, 20 Station Close, Potters Bar, EN6 1TL, United Kingdom

Haupt Pharma, 1 rue Comte de Sinard, Livron Sur Drome, 26250, France

The information in this leaflet applies only to Syntocinon. If you have any questions or you are not sure about anything, ask your doctor, midwife or a pharmacist.

This leaflet was last revised in January 2026

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 48300/0003

Last revision stated in the text: January 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Syntocinon 10 IU/ml concentrate for solution for infusion

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Oxytocin
Strength 10 IU/ml
Excipients Sodium acetate tri-hydrate, sodium chloride, acetic acid and water for injections.
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life Five years
Chemical and physical in-use stability has been demonstrated for 24 hours at room temperature (15 °C to 25 °C).
From a microbiological point of view, unless the method of opening/ reconstitution/ dilution precludes the risk of microbial contamination, the product should be used immediately. If not used immediately, in-use storage times and conditions are the responsibility of the user
Storage Store between 2°C and 8°C.
Drug group (ATC) Posterior pituitary lobe hormones
  1. H Systemic hormonal preparations, excl. sex hormones and insulins
    1. H01 Pituitary and hypothalamic hormones and analogues
      1. H01B Posterior pituitary lobe hormones
        1. H01BB Oxytocin and analogues
          1. H01BB02 oxytocin
Marketing authorisation PL 48300/0003, PL 51412/0007 (first authorised 25 June 1998)
Marketing authorisation holder Laboratorios Farmalan, S.A.

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.